Two analysts in a Capital IQ poll had expected a net profit of $0.13 per share for the quarter.
Price: 10.29, Change: 0.00, Percent Change: 0.00
|MT Newswires After Hours Watch List: ABCL, FANG, GRTS|
|Kymera Therapeutics Chief Scientific Officer Cheswor...|
|Update: AbCellera Jumps 20% After Hours as FDA Expan...|
|Insider Buy: Oscar Health|
|Insider Sell: Outset Medical|